Mr. McCarrey has more than 15 years of experience in medical device sales. He recently served as the executive vice president of North American cardiovascular sales for Bayer International.
AxoGen, a medical device company with a focus on peripheral nerve repair, is trying to shift its focus from early adoption to broad usage in surgical nerve repair, according to the release. Mr. McCarrey will work to increase sales and implement strategic growth initiatives.
More Articles on Devices:
Lanx Releases ALTA Cervical Spine Fusion Device
TranS1 Acquires Baxano Spine Device Manufacturer at $23.6M
12 News Updates for Orthopedic & Spine Device Companies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.